Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Time for this forum to get back on track.

You say:

"That said, although I would be happy to be proved wrong, I am in DISagreement with any post suggesting an immediate or sustainable 5-6+ fold surge in price solely upon notification of a standing REcert of the 336. For all kind of reasons, I am UNconvinced that the 336 notification will be the "end game" as far as PTSC's languishing stock price problems."

But on 3/26/10, you said:

"Who said "$5" per share ? Bring it on, we've been waiting.

My Ts & Os"

However, preceeding the above comment, you did say:

"For the price to rise from these or lower levels at some point is a given, but internal and external dynamics impacting this company are far different than what they were in early 2006."

To that, I agree. Unlike in 2006 and a while after, we no longer need to worry (to a significant degree) about the "Swartz effect".

But I have to say that I cannot further criticize what you suggest.

I KNOW I joined a thread of optimism, and I expressed perhaps overzealous optimism. So your expression of caution is welcome and appropriate, and provides desired "balance" to the conversation.

Thank you for your input.

Sincerely,

SGE

Share
New Message
Please login to post a reply